193 related articles for article (PubMed ID: 37821382)
1. m6A-Modified circTET2 Interacting with HNRNPC Regulates Fatty Acid Oxidation to Promote the Proliferation of Chronic Lymphocytic Leukemia.
Wu Z; Zuo X; Zhang W; Li Y; Gui R; Leng J; Shen H; Pan B; Fan L; Li J; Jin H
Adv Sci (Weinh); 2023 Dec; 10(34):e2304895. PubMed ID: 37821382
[TBL] [Abstract][Full Text] [Related]
2. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
4. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway.
Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ
Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA.
Zhou Y; Xue X; Luo J; Li P; Xiao Z; Zhang W; Zhou J; Li P; Zhao J; Ge H; Tian Z; Zhao X
Cancer Sci; 2023 Sep; 114(9):3608-3622. PubMed ID: 37417427
[TBL] [Abstract][Full Text] [Related]
6. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
[TBL] [Abstract][Full Text] [Related]
7. METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
Wu Y; Jin M; Fernandez M; Hart KL; Liao A; Ge X; Fernandes SM; McDonald T; Chen Z; Röth D; Ghoda LY; Marcucci G; Kalkum M; Pillai RK; Danilov AV; Li JJ; Chen J; Brown JR; Rosen ST; Siddiqi T; Wang L
Blood Cancer Discov; 2023 May; 4(3):228-245. PubMed ID: 37067905
[TBL] [Abstract][Full Text] [Related]
8. New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC.
Cheng W; Li M; Zhang L; Zhou C; Yu S; Peng X; Zhang W; Zhang W
Front Pharmacol; 2022; 13():973116. PubMed ID: 36120320
[TBL] [Abstract][Full Text] [Related]
9. HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells.
Gu Z; Yang Y; Ma Q; Wang H; Zhao S; Qi Y; Li Y
Respir Res; 2022 Dec; 23(1):362. PubMed ID: 36536402
[TBL] [Abstract][Full Text] [Related]
10. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
11. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
12. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
[TBL] [Abstract][Full Text] [Related]
13. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.
Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p/PML axis.
Wu W; Wu Z; Xia Y; Qin S; Li Y; Wu J; Liang J; Wang L; Zhu H; Fan L; Fu J; Xu W; Jin H; Li J
Aging (Albany NY); 2019 Jun; 11(11):3561-3573. PubMed ID: 31152142
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value and multiomic features of m6A-related risk signature in lung adenocarcinoma.
Wang X; Yu Q; Yu H; Wang Y; Sun L; Yu L; Cui H; Yang H
Am J Transl Res; 2022; 14(8):5379-5393. PubMed ID: 36105012
[TBL] [Abstract][Full Text] [Related]
16. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner.
Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P
Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.
Xia L; Wu L; Bao J; Li Q; Chen X; Xia H; Xia R
Biochem Biophys Res Commun; 2018 Sep; 503(1):385-390. PubMed ID: 29902450
[TBL] [Abstract][Full Text] [Related]
19. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of c-Myc-dependent heterogeneous nuclear ribonucleoprotein A1 promotes proliferation and inhibits apoptosis in NOTCH1-mutated chronic lymphocytic leukemia cells.
Zou Y; Tang H; Miao Y; Zhu H; Wang L; Fan L; Fu J; Xu W; Li J; Xia Y
Chin Med J (Engl); 2022 Apr; 135(8):920-929. PubMed ID: 35730371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
